2025-11-12T15:35:50-06:00 2024-12-31 390919055 RITZ HOLMAN LLP 330 E KILBOURN AVE SUITE 222 MILWAUKEE WI 53202 990 2024-01-01 391554806 SOCIETY FOR IMMUNOTHERAPY OF CANCER INC SOCI 4142712456 555 E WELLS STREET 1100 MILWAUKEE WI 53202 PAMELA S OHASHI PHD SECRETARY/TREASURER 4142712456 2025-11-12 1 0 KATY L SOMMER P00273273 4142711451 2025-11-12 2024 2025-03-06 01:10:19Z JAMES L GULLEY MD PHD 555 E WELLS STREET 1100 MILWAUKEE WI 53202 12891156 0 X WWW.SITCANCER.ORG X 1986 WI TO IMPROVE CANCER PATIENT OUTCOMES BY ADVANCING THE SCIENCE, DEVELOPMENT AND APPLICATION OF CANCER IMMUNOLOGY AND IMMUNOTHERAPY THROUGH OUR CORE VALUES OF INTERACTION/INTEGRATION, INNOVATION, TRANSLATION, DIVERSITY AND INCLUSION AND LEADERSHIP IN THE FIELD. SITC AIMS TO MAKE CANCER IMMUNOTHERAPY A STANDARD OF CARE AND THE WORD "CURE" A REALITY FOR CANCER PATIENTS EVERYWHERE. 13 13 0 259 73000 70695 3448837 2256264 11184715 10044421 366609 458620 211402 77281 15211563 12836586 750180 908704 0 0 14750 5000 0 0 52070 14519441 13222745 15284371 14136449 -72808 -1299863 22459068 21858862 1454218 1553613 21004850 20305249 X TO IMPROVE CANCER PATIENT OUTCOMES BY ADVANCING THE SCIENCE, DEVELOPMENT AND APPLICATION OF CANCER IMMUNOLOGY AND IMMUNOTHERAPY THROUGH OUR CORE VALUES OF INTERACTION/INTEGRATION, INNOVATION, TRANSLATION, DIVERSITY AND INCLUSION AND LEADERSHIP IN THE FIELD. SITC AIMS TO MAKE CANCER IMMUNOTHERAPY A STANDARD OF CARE AND THE WORD "CURE" A REALITY FOR CANCER PATIENTS EVERYWHERE. 0 0 6261769 6409534 THE SOCIETY FOR IMMUNOTHERAPY OF CANCER'S (SITC) 39TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2024) PROVIDED A MULTIDISCIPLINARY EDUCATIONAL AND INTERACTIVE ENVIRONMENT FOCUSED ON IMPROVING THE OUTCOME FOR CURRENT AND FUTURE PATIENTS WITH CANCER BY INCORPORATING STRATEGIES BASED ON BASIC AND APPLIED CANCER IMMUNOTHERAPY. THE ANNUAL MEETING CONSISTED OF CUTTING-EDGE RESEARCH PRESENTATIONS BY EXPERTS IN THE FIELD, ORAL AND POSTER ABSTRACT PRESENTATIONS AND AMPLE OPPORTUNITY FOR STRUCTURED AND INFORMAL DISCUSSIONS, INCLUDING IMPORTANT NETWORKING OPPORTUNITIES. IN ADDITION, THE MEETING INCLUDES UPDATES ON MAJOR NATIONAL AND INTERNATIONAL INITIATIVES COMING FROM ACADEMIA, GOVERNMENT AND INDUSTRY, AS WELL AS IMPORTANT SOCIETY PROJECTS. 618457 CIG PROGRAM - THE SITC CANCER IMMUNOTHERAPY GUIDELINES PROGRAM IS A COLLECTION OF CLINICAL PRACTICE GUIDELINES (CPGS) DEVELOPED BY MULTI-DISCIPLINARY PANELS OF EXPERTS WHO DRAW FROM THEIR OWN PRACTICAL EXPERIENCE AS WELL AS EVIDENCE IN THE PUBLISHED LITERATURE AND CLINICAL TRIAL DATA TO DEVELOP EVIDENCE- AND CONSENSUS-BASED RECOMMENDATIONS ON WHEN AND HOW TO USE IMMUNOTHERAPY TO HELP IMPROVE OUTCOMES FOR PATIENTS WITH CANCER. THESE CPGS OFFER A VITAL RESOURCE FOR THE PRACTICING ONCOLOGY COMMUNITY. SITC USES AS A MODEL THE INSTITUTE OF MEDICINE'S 2011 "STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES" TO ENSURE A FAIR, TRANSPARENT AND BALANCED PROCESS FOR CREATING THE CPGS. EACH CPG EXPERT PANEL IS COMPRISED OF A COMPREHENSIVE MIX OF ACADEMIC PHYSICIANS AND RESEARCHERS, NURSES, PATIENTS, AND PATIENT ADVOCATES INVITED FROM INSTITUTIONS ACROSS THE UNITED STATES. 354970 20930 THE ADVANCES IN CANCER IMMUNOTHERAPY (ACI) SERIES HOSTED TEN CME-, CNE-, CPE-, AND MOC- CERTIFIED PROGRAMS IN 2024. TWO OF THE PROGRAMS WERE HELD IN PERSON AT SUBSPECIALTY GROUP MEETINGS, AND EIGHT OF THE PROGRAMS WERE HELD VIRTUALLY ONLY. THE SERIES WAS DESIGNED TO PROVIDE EDUCATION TO PATIENT CARE PROVIDERS AND OTHERS WHO WISH TO LEARN THE BASIC PRINCIPLES OF TUMOR IMMUNOLOGY AND IMMUNOTHERAPY, AND TO IMPROVE THEIR ABILITY TO INTEGRATE IMMUNOTHERAPY INTO STATE-OF-THE-ART CLINICAL MANAGEMENT FOR THEIR PATIENTS. THIS INTENDED AUDIENCE INCLUDED CLINICAL ONCOLOGISTS, REGISTERED NURSES, ADVANCED PRACTITIONERS, PHARMACISTS, EMERGENCY PHYSICIANS, PATHOLOGISTS, SURGEONS, RADIATION ONCOLOGISTS, ALLIED HEALTH PROFESSIONALS, AND OTHER PATIENT CARE PROVIDERS, STUDENTS AND PATIENT ADVOCATES. 4724426 908704 3627758 WORKSHOP / CONNECTED / PRIMER / WIC/ INDUSTRY / WINTER / WIN / SPAKATHON PROGRAM / JOURNAL / COLLABORATIVE EDUCATION PROGRAMS / CIG / POLICY ACTIVITIES / SCIENTIFIC RESOURCES / CERTIFICATE PROGRAM / DIVERSITY, EQUITY AND INCLUSION / ENGINEERING AND IO / FAIO / OTHER PROGRAM SERVICES 4724426 908704 3627758 11959622 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 67 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 X 13 13 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X EXECUTIVE DIRECTOR INC 4142766445 555 E WELLS ST SUITE 1100 MILWAUKEE WI 53202 LEISHA EMENS MD PHD PRESIDENT 5.00 X X 0 0 0 JAMES GULLEY MD PHD VICE PRESIDENT 5.00 X X 0 0 0 PATRICK HWU MD IMM. PAST PRES. 5.00 X X 0 0 0 JULIE BRAHMER MD DIRECTOR 1.00 X 0 0 0 JENNIFER GUERRIERO PHD DIRECTOR 1.00 X 2000 0 0 JENNIFER WARGO MD MMSC DIRECTOR 1.00 X 0 0 0 JASON LUKE MD PHD DIRECTOR 1.00 X 0 0 0 SARAH WARREN PHD DIRECTOR 1.00 X 0 0 0 TULLIA BRUNO PHD DIRECTOR 1.00 X 2000 0 0 PAMELA OHASHI PHD SECR/TREASURER 5.00 X X 0 0 0 ARLENE SHARPE MD PHD FAIO DIRECTOR 1.00 X 0 0 0 AVERY POSEY JR PHD DIRECTOR 1.00 X 0 0 0 CRYSTAL PAULOS PHD DIRECTOR 1.00 X 1000 0 0 5000 0 0 0 0 0 0 EXECUTIVE DIRECTOR INC 555 E WELLS ST STE 1100 MILWAUKEE WI 53202 MANAGEMENT 6759233 CORNERSTONE GOVERNMENT AFFAIRS INC 300 INDEPENDENCE AVE SE WASHINGTON DC 20003 CONSULTING 160000 2 36313 2219951 2256264 ANNUAL MEETING 900099 6336534 6336534 MEMBERSHIP DUES & ASSESSMENTS 900099 1840040 1840040 OTHER REGISTRATION PROGRAMS 900099 673469 673469 PUBLISHER REVENUE 900099 520753 520753 PRIMER 900099 227605 227605 446020 446020 10044421 458620 458620 1772 1772 39500 36313 50792 -11292 -11292 4591 3778 813 813 ADVERTISING 541800 73000 73000 MISCELLANEOUS 900099 12988 12988 85988 12836586 10058222 73000 449100 737618 737618 6337 6337 164749 164749 5000 5000 6759233 5268633 1472600 18000 19504 19304 200 18975 18975 24095 24095 156000 156000 272555 223978 47130 1447 67445 17425 26596 23424 353997 184582 169415 688123 596435 91688 4459640 4326491 126522 6627 6493 6493 BANK AND CC FEES 226400 198448 25380 2572 EXHIBITING 85683 7386 78297 MISCELLANEOUS 35718 287 35431 PROFESSIONAL DEVELOPMEN 27139 27139 21745 19810 1935 14136449 11959622 2124757 52070 5615756 3417889 6637682 6761432 435000 2000 202254 357310 2220 1434 415828 415636 0 0 9133809 10882892 16519 20269 22459068 21858862 146563 140973 1307655 1312640 0 100000 1454218 1553613 X 18096662 17174187 2908188 3131062 21004850 20305249 22459068 21858862 -1299863 600262 0 X 0 1 X 1 0 X 4073183 5062145 4171964 3448837 2256264 19012393 2327126 8775539 12615726 11184714 10044421 44947526 6400309 13837684 16787690 14633551 12300685 63959919 2177500 2312500 2880500 999000 1007109 9376609 0 2177500 2312500 2880500 999000 1007109 9376609 54583310 95837 178317 189695 366609 460392 1290850 95837 178317 189695 366609 460392 1290850 65266 157366 178088 91500 73000 565220 12139 12191 37582 90456 12988 165356 6573551 14185558 17193055 15182116 12847065 65981345 0.82730 0.76720 0.01960 0.01480 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2020 AMOUNT: $ 12,139. 2021 AMOUNT: $ 12,191. 2022 AMOUNT: $ 37,582. 2023 AMOUNT: $ 90,456. 2024 AMOUNT: $ 12,988. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2231708 835227 217769 155678 3129026 2076283 810232 183288 838095 2231708 1690822 658661 273200 2076283 1840822 150000 1690822 1.00000 0 0 0 LONG TERM DEFERRED REVENUE - GRANTS 100000 100000 X 13463545 600262 50792 651054 12812491 24095 24095 12836586 14163146 50792 50792 14112354 24095 24095 14136449 PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION. HOWEVER, INCOME FROM CERTAIN ACTIVITIES (PRIMARILY ADVERTISING INCOME) NOT DIRECTLY RELATED TO THE ORGANIZATION'S TAX EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. UNRELATED BUSINESS INCOME TAX EXPENSE FOR THE YEAR ENDED DECEMBER 31, 2024, WAS $1,935. $5,685 OF ESTIMATED TAX PAYMENTS WERE MADE FOR THE YEAR ENDED DECEMBER 31, 2024. AN UNRELATED BUSINESS INCOME TAX DEPOSIT OF $20,269 WAS RECORDED AS OF DECEMBER 31, 2024. MANAGEMENT HAS REVIEWED ALL TAX POSITIONS RECOGNIZED IN PREVIOUSLY FILED TAX RETURNS AND THOSE EXPECTED TO BE TAKEN IN FUTURE TAX RETURNS. AS OF DECEMBER 31, 2024, THE ORGANIZATION HAD NO AMOUNTS RELATED TO UNRECOGNIZED INCOME TAX BENEFITS AND NO AMOUNTS RELATED TO ACCRUED INTEREST AND PENALTIES. THE ORGANIZATION DOES NOT ANTICIPATE ANY SIGNIFICANT CHANGES TO UNRECOGNIZED INCOME TAX BENEFITS OVER THE NEXT YEAR. PART XI, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES INCLUDED IN REVENUE 50,792. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EVENT EXPENSES INCLUDED IN REVENUE 50,792. 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 11 PROGRAM SERVICES JOURNAL EDITORIAL SERVICES, MAC CHEEVER AWARDS & HONORARIUMS 43626 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 6 PROGRAM SERVICES JOURNAL EDITORIAL SERVICES & HONORARIUMS 1500 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 5 PROGRAM SERVICES HONORARIUMS 19623 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 2 PROGRAM SERVICES FELLOWSHIP AWARD 100000 0 24 0 0 0 24 164749 0 164749 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES FELLOWSHIP AWARD 50000 WIRE TRANSFER 0 FMV NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES FELLOWSHIP AWARD 100000 WIRE TRANSFER 0 FMV 2 0 0 0 0 0 0 BUDDY GUY'S FUNDRAISING 75813 36313 39500 50792 75813 36313 39500 50792 50792 -11292 1 BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVE BOSTON MA 02115 042774441 501(C)(3) 120000 0 FMV FELLOWSHIP AWARD CASE WESTERN RESERVE UNIVERSITY 10900 EUCLID AVE CLEVELAND OH 441067006 341018992 501(C)(3) 197618 0 FMV FELLOWSHIP AWARD MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVE CAMBRIDGE MA 021394307 042103594 501(C)(3) 75000 0 FMV ROSENBERG AWARD NORTHWESTERN UNIVERSITY 633 CLARK ST EVANSTON IL 60208 362167817 501(C)(3) 50000 0 FMV FELLOWSHIP AWARD THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER PO BOX 4266 HOUSTON TX 772104266 746001118 501(C)(3) 125000 0 FMV FELLOWSHIP AWARD NATIONAL CANCER INSTITUTE 9000 ROCKVILLE PIKE BETHESDA MD 20892 522858115 501(C)(3) 50000 0 FMV FELLOWSHIP AWARD STANFORD UNIVERSITY BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERS PO BOX 884253 LOS ANGELES CA 900884253 941156365 501(C)(3) 50000 0 FMV FELLOWSHIP AWARD THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA OFFICE OF RESEARCH SERVICES 5TH FLOOR FRANKLIN BLDG 3451 WALNUT ST PHILADELPHIA PA 19104 231352685 501(C)(3) 20000 0 FMV FELLOWSHIP AWARD UNIVERSITY OF COLORADO DENVER PO BOX 910238 DENVER CO 802910238 846000555 501(C)(3) 50000 0 FMV FELLOWSHIP AWARD 9 PRESIDENTIAL AWARD 5 4250 FMV JOURNAL AWARD 2 1000 FMV MAC CHEEVER AWARD 1 1087 FMV PART I, LINE 2: THE PRESIDENTIAL AWARD AND PRESIDENTIAL TRAVEL AWARDS ARE PRESENTED TO THE TOP FOUR SELECTED ABSTRACTS AUTHORED BY YOUNG INVESTIGATORS. THE JITC BEST PAPER AWARDS ARE PRESENTED TO THE BEST PAPER AUTHORS SUBMITTED IN THE CLINICAL/TRANSLATIONAL AND BASIC SCIENCE CATEGORIES. THE SITC ABSTRACT TRAVEL AWARDS ARE PRESENTED TO THE TOP SCORING ABSTRACTS FROM YOUNG INVESTIGATORS. THE AWARDS ARE PRESENTED DURING THE ANNUAL MEETING AND THE TRAVEL AWARDS RECIPIENTS ARE REIMBURSED FOR THEIR TRAVEL EXPENSES AFTER QUALIFYING RECEIPTS ARE SUBMITTED UP TO THE PRE-DETERMINED AWARD LIMIT. JUDGING OF THE ABSTRACT PRESENTATIONS AND AWARDS ARE DONE BY A COMMITTEE OF SITC LEADERSHIP. FOR WINTER SCHOOL TRAVEL AWARDS, STAFF COLLECTS REIMBURSEMENT FORMS LISTING ALL EXPENSES AND QUALIFYING RECEIPTS FOR ALL EXPENSES INCURRED AFTER THE MEETING. FELLOWSHIP RECIPIENTS PROVIDE A MIDWAY AND FINAL REPORT THAT INCLUDES THEIR PROGRESS ON THE FUNDED PROJECT AND THE DISTRIBUTION OF THE AWARDED FUNDS TO DATE. THE MIDWAY REPORT MUST BE APPROVED BY THE EXECUTIVE COMMITTEE BEFORE THE SECOND HALF OF THE AWARDED FUNDS ARE DISPERSED. THE FINAL REPORT IS REVIEWED BY BOTH THE AWARDS REVIEW COMMITTEE AND THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION A, LINE 3 LINE 3 EXPLANATION - SITC IS IN CONTRACT WITH EXECUTIVE DIRECTOR, INC., AN ASSOCIATION MANAGEMENT COMPANY. FORM 990, PART VI, SECTION A, LINE 6 LINE 6 EXPLANATION - THE SOCIETY CONSISTS OF NINE CLASSES OF MEMBERSHIP: REGULAR, EMERITUS, AFFILIATE, STUDENT AND SCIENTIST-IN-TRAINING, ALLIED HEALTH, NURSE AND ADVANCED PRACTICE PROVIDER, PATIENT AND PATIENT ADVOCATE, PHARMACIST AND CORPORATE. FORM 990, PART VI, SECTION A, LINE 7A LINE 7A EXPLANATION - REGULAR AND EMERITUS MEMBERS IN GOOD STANDING ARE ENTITLED TO VOTE ON THE ELECTION OF THE OFFICERS-DIRECTORS OF THE SOCIETY. VOTING TAKES PLACE EACH YEAR AT THE ANNUAL SCIENTIFIC AND BUSINESS MEETING UNLESS PREVIOUSLY HELD BY WRITTEN BALLOT. FORM 990, PART VI, SECTION A, LINE 7B LINE 7B EXPLANATION - ONLY REGULAR AND EMERITUS MEMBERS IN GOOD STANDING ARE ENTITLED TO VOTE ON ALL MATTERS TO BE VOTED ON BY MEMBERS OF THE SOCIETY. FORM 990, PART VI, SECTION B, LINE 11B LINE 11B EXPLANATION - THE FORM 990 AND ALL APPLICABLE SCHEDULES ARE DISTRIBUTED TO THE FINANCE COMMITTEE FOR REVIEW AND DISCUSSION. THE FINANCE COMMITTEE RECOMMENDS THE BOARD TO APPROVE THE FORM 990. ONCE APPROVED, THE 990 TAX FORM IS SIGNED BY A SELECTED OFFICER AND FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C MEMBERS OF THE BOARD OF DIRECTORS, EXECUTIVE COUNCIL, AND COMMITTEE CHAIRS ARE COVERED UNDER THE POLICY. ANY POSSIBLE CONFLICTS OF INTEREST DISCLOSED ARE REVIEWED BY THE EXECUTIVE DIRECTOR AND ARE BROUGHT FORWARD TO THE BOARD OF DIRECTORS FOR FURTHER INVESTIGATION, REVIEW AND DETERMINATION OF THE APPROPRIATE DISCIPLINARY ACTIONS. POSSIBLE CONFLICTS DISCLOSED BEFORE A MEETING ARE REVIEWED BY THE PRESIDENT, PRESIDING OFFICER OR COMMITTEE CHAIR PERSON TO DETERMINE WHETHER OR NOT THE CONFLICT IS INAPPROPRIATE FOR THE MEMBER TO CONTRIBUTE TO THE CONVERSATION. THE RESTRICTIONS IMPOSED ON PERSONS WITH A CONFLICT ARE WITHDRAWAL FROM DISCUSSION AND VOTING ON THE MATTER. FORM 990, PART VI, SECTION B, LINE 15 SITC DOES NOT COMPENSATE ANY OF ITS OFFICERS OR BOARD MEMBERS. THE SOCIETY ALSO DOES NOT HAVE ANYONE THAT FITS THE DEFINITION OF A KEY EMPLOYEE. SITC IS MANAGED BY EXECUTIVE DIRECTOR, INC., A FOR-PROFIT MANAGEMENT COMPANY. SITC HAS NO OFFICIAL EMPLOYEES BECAUSE ALL STAFF ASSIGNED TO SITC ARE EMPLOYEES OF THE MANAGEMENT COMPANY. SITC DOES NOT COMPENSATE ANY OF ITS OFFICERS OR BOARD MEMBERS. THE SOCIETY ALSO DOES NOT HAVE ANYONE THAT FITS THE DEFINITION OF A KEY EMPLOYEE. FORM 990, PART VI, SECTION C, LINE 19 SITC MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FORM 990 AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. REQUEST SHOULD BE MADE TO THE SITC OFFICE AND DOCUMENTS ARE PROVIDED WITHIN A REASONABLE TIMEFRAME VIA MAIL OR E-MAIL. THE BYLAWS CAN ALSO BE FOUND ON THE SITC WEBSITE.